Across TCGA pan-cancer cohorts, RPL21P91 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPL21P91’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where RPL21P91 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL21P91 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD are the cancer types where RPL21P91 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL21P91 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.270	.005	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RPL21P91 RNA expression & survival · all RPL21P91 data types